The New York Times recently reported that in the darkest moments of the triple meltdown last year of the Fukushima Daiichi nuclear power plant, Japanese officials considered the evacuation of the nearly 36 million residents of the Tokyo metropolitan area.

President & Chairman Simon Chin of Iris BioTechnologies (OTCBB: IRSB), the Santa Clara, California-based theranostics company, that is focused on developing and commercializing the Nano-Biochip(TM), a gene expression system that identifies the most effective, reliable, and personalized treatment option for patients, was included in the "PharmaVOICE 100," an annual list of individuals who are having a remarkable influence on the life sciences industry.

By Trevor Jensen, Chicago Tribune Feb. 6--Joseph J. Katz worked on the Manhattan Project in the 1940s and during a long career at Argonne National Laboratory made breakthroughs in the mysteries of photosynthesis thanks to his curiosity about the effects of so-called heavy water on plant life. Dr.